In more mature patients, this is critical to know as polypharmacy is common and might potentiate the potential risk of DDIs and ADRs. Hence, concurrent consumption of CYP2D6 inhibitors or inducers could potentiate or block tramadol conversion into ODT and This might raise or reduce efficacy/ADRs with the prescribed https://hemalchem.com/product/o-dsmt/